BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 218300)

  • 1. [Second malignacies complicating Hodgkin's disease. 1 case].
    Blanc AP; Gastaut JA; Carcassonne Y
    Sem Hop; 1979 Jan 8-15; 55(1-2):80-2. PubMed ID: 218300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute myeloid leukemia during Hodgkin's disease].
    Dziewulska-Bokiniec A; Jassem J
    Acta Haematol Pol; 1979; 10(2):137-40. PubMed ID: 289273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second malignant neoplasms in patients successfully treated for Hodgkin's disease: a Cancer and Leukemia Group B study.
    Glicksman AS; Pajak TF; Gottlieb A; Nissen N; Stutzman L; Cooper MR
    Cancer Treat Rep; 1982 Apr; 66(4):1035-44. PubMed ID: 6951632
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute myelogenous leukemia 11 years after successful treatment of Hodgkin's disease. A contribution to the problem of secondary tumors].
    Ritter J; Oehme J
    Med Klin; 1978 Sep; 73(39):1360-2. PubMed ID: 279796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Letter: Secondary neoplasms complicating Hodgkin's disease].
    Focan C; Brictieux N; Lemaire M; Hugues J
    Nouv Presse Med; 1974 May; 3(21):1385. PubMed ID: 4527420
    [No Abstract]   [Full Text] [Related]  

  • 7. Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin's disease.
    Henry-Amar M
    J Natl Cancer Inst; 1983 Nov; 71(5):911-6. PubMed ID: 6580491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
    Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
    Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second malignancy complicating Hodgkin's disease.
    Tawil E; Mercier JP
    J Can Assoc Radiol; 1983 Jun; 34(2):108-13. PubMed ID: 6688422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors.
    Meadows AT; Obringer AC; Marrero O; Oberlin O; Robison L; Fossati-Bellani F; Green D; Voƻte PA; Morris-Jones P; Greenberg M
    Med Pediatr Oncol; 1989; 17(6):477-84. PubMed ID: 2586362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of terminal leukemia in a patient with Hodgkin's disease].
    Quaglino D; Emilia G; Di Prisco AU; De Pasquale A; Zagni G
    Minerva Med; 1975 Feb; 66(15):689-98. PubMed ID: 1054112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer and secondary leukemia.
    Rosner F
    Bull Cancer; 1983; 70(1):55-60. PubMed ID: 6573207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
    Valagussa P; Bonadonna G
    Haematologica; 1998 Sep; 83(9):769-70. PubMed ID: 9825571
    [No Abstract]   [Full Text] [Related]  

  • 14. [Simultaneous and successive neoplastic disease. Apropos of 18 cases of malignant diseases complicating the evolution of Hodgkin's disease].
    Jacquillat C; Belpomme D; Weil M; Auclerc G; Teillet F; Weisgerber C; Tanzer J; Boiron M; Bernard J
    Nouv Presse Med; 1973 Dec; 2(46):3089-92. PubMed ID: 4522824
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute myeloid leukemia following therapy of Hodgkin's disease with radiotherapy and ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine).
    Lipton JH; Gospodarowicz M; Reingold S
    Hematol Oncol; 1996 Mar; 14(1):29-31. PubMed ID: 8613133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute myeloid leukemia after treatment of Hodgkin's disease].
    Carneiro PC; Pereira ED; Mitteldorf CS; Martinez GA; Beitler B; Pozzi DH
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(2):87-90. PubMed ID: 2616992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of second tumors in patients with Hodgkin's disease (review of the literature and personal data)].
    Kanaev SV; Kholin AV; Gershanovich ML; Malinin AP
    Vopr Onkol; 1987; 33(5):11-8. PubMed ID: 3590664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second malignancies complicating Hodgkin's disease: a Southwest Oncology Group 10-year followup.
    Coltman CA; Dixon DO
    Cancer Treat Rep; 1982 Apr; 66(4):1023-33. PubMed ID: 7074630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second neoplasms in Hodgkin's disease: current controversies.
    Zarrabi MH; Rosner F
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):303-18. PubMed ID: 2663829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary leukemia and myelodysplastic syndrome after treatment for Hodgkin's disease.
    Hoppe RT
    Leukemia; 1992 Nov; 6 Suppl 4():155-7. PubMed ID: 1434819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.